Huron Consulting (HURN) is well-positioned to capitalize on double-digit growth in core verticals as more clients seek the company's support to navigate heightened market volatility, Wedbush said in a Wednesday note.
The company's Q4 print indicated strength in healthcare and commercial segments amid continued demand for its digital offerings alongside M&A strategy, analysts wrote.
Healthcare segment growth in Q4 was driven by robust demand across its portfolio, including the launch of new AI and automation services, according to the note.
Huron continues to generate steady deal flow, and its recent acquisitions reflect the company's strategic investments in new industry expertise to boost win rates, according to Wedbush.
The brokerage said it reiterated its outperform rating on the stock and price target of $200 per share.
Price: 120.52, Change: -5.84, Percent Change: -4.62